Drawing for TRANSFORMING MEDICINE AT THE CARDIORENAL CROSSROADS

USPTO serial 77267986

TRANSFORMING MEDICINE AT THE CARDIORENAL CROSSROADS

Reviewed by CopyMark Law Group

Reg. 3944591Status 710
Filing date
Status date
Registration date
Apr 12, 2011
Examiner
BUTLER, ANDREA P
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with TRANSFORMING MEDICINE AT THE CARDIORENAL CROSSROADS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bingham B. Leverich, Esq.

Marie A. Lavalleye Covington & Burling LLP1201 PENNSYLVANIA AVENUE, N.W.WASHINGTON, DC 20004UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Internet website providing information on clinical trials for existing and prospective pharmaceutical productsSECTION 8 - CANCELLED—
044Health information services, namely, providing information to patients on topics of cardiorenal diseases and disorders, the prevention, diagnosis and treatment of cardiorenal diseases and disorders, and dosing options of pharmaceuticals for the treatment and prevention of cardiorenal diseases and disorders; providing links to the websites of others featuring information about the prevention, diagnosis and treatment of cardiorenal diseases and disordersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 17, 2017C8..CANCELLED SEC. 8 (6-YR)—
Apr 12, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 11, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 10, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Mar 8, 2011ALIEASSIGNED TO LIE—
Mar 7, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 23, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 22, 2011IUAFUSE AMENDMENT FILED—
Feb 22, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 25, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 24, 2010EX5GSOU EXTENSION 5 GRANTED—
Jun 21, 2010EXT5SOU EXTENSION 5 FILED—
Jun 21, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 21, 2010CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 21, 2010COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 20, 2010EX4GSOU EXTENSION 4 GRANTED—
Jan 19, 2010EXT4SOU EXTENSION 4 FILED—
Jan 19, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 23, 2009EX3GSOU EXTENSION 3 GRANTED—
Jul 23, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 30, 2009EXT3SOU EXTENSION 3 FILED—
Jun 30, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 5, 2009EX2GSOU EXTENSION 2 GRANTED—
Feb 5, 2009EXT2SOU EXTENSION 2 FILED—
Feb 5, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 14, 2008EX1GSOU EXTENSION 1 GRANTED—
Aug 14, 2008EXT1SOU EXTENSION 1 FILED—
Aug 14, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 25, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 1, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 12, 2007NPUBNOTICE OF PUBLICATION—
Nov 27, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 27, 2007ALIEASSIGNED TO LIE—
Oct 23, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2007DOCKASSIGNED TO EXAMINER—
Sep 4, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance